148 related articles for article (PubMed ID: 28291260)
1. Gene expression and proliferation biomarkers for antidepressant treatment resistance.
Breitfeld J; Scholl C; Steffens M; Laje G; Stingl JC
Transl Psychiatry; 2017 Mar; 7(3):e1061. PubMed ID: 28291260
[TBL] [Abstract][Full Text] [Related]
2. Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.
Breitfeld J; Scholl C; Steffens M; Brandenburg K; Probst-Schendzielorz K; Efimkina O; Gurwitz D; Ising M; Holsboer F; Lucae S; Stingl JC
Transl Psychiatry; 2016 Nov; 6(11):e950. PubMed ID: 27845776
[TBL] [Abstract][Full Text] [Related]
3. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.
Barakat AK; Scholl C; Steffens M; Brandenburg K; Ising M; Lucae S; Holsboer F; Laje G; Kalayda GV; Jaehde U; Stingl JC
Transl Psychiatry; 2020 Jul; 10(1):210. PubMed ID: 32612257
[TBL] [Abstract][Full Text] [Related]
4. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.
Probst-Schendzielorz K; Scholl C; Efimkina O; Ersfeld E; Viviani R; Serretti A; Fabbri C; Gurwitz D; Lucae S; Ising M; Paul AM; Lehmann ML; Steffens M; Crisafulli C; Calabrò M; Holsboer F; Stingl J
Pharmacogenomics; 2015; 16(7):689-701. PubMed ID: 25943212
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.
Marchetti L; Lauria M; Caberlotto L; Musazzi L; Popoli M; Mathé AA; Domenici E; Carboni L
Eur Neuropsychopharmacol; 2020 Feb; 31():69-85. PubMed ID: 31813757
[TBL] [Abstract][Full Text] [Related]
6. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.
Morag A; Pasmanik-Chor M; Oron-Karni V; Rehavi M; Stingl JC; Gurwitz D
Pharmacogenomics; 2011 Feb; 12(2):171-84. PubMed ID: 21332311
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
Fabbri C; Serretti A
Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
[TBL] [Abstract][Full Text] [Related]
9. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
Nackenoff AG; Moussa-Tooks AB; McMeekin AM; Veenstra-VanderWeele J; Blakely RD
Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584
[TBL] [Abstract][Full Text] [Related]
10. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
11. Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
Eyre HA; Eskin A; Nelson SF; St Cyr NM; Siddarth P; Baune BT; Lavretsky H
Int J Geriatr Psychiatry; 2016 May; 31(5):510-7. PubMed ID: 26471432
[TBL] [Abstract][Full Text] [Related]
12. Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial.
Olgiati P; Bajo E; Bigelli M; Montgomery S; Serretti A;
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1739-46. PubMed ID: 24075716
[TBL] [Abstract][Full Text] [Related]
13. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
Li Y; Abdourahman A; Tamm JA; Pehrson AL; Sánchez C; Gulinello M
Pharmacol Biochem Behav; 2015 Aug; 135():70-82. PubMed ID: 26046533
[TBL] [Abstract][Full Text] [Related]
14. Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways.
Morag A; Kirchheiner J; Rehavi M; Gurwitz D
Pharmacogenomics; 2010 Mar; 11(3):327-40. PubMed ID: 20235789
[TBL] [Abstract][Full Text] [Related]
15. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
16. Increased cellular turnover in response to fluoxetine in neuronal precursors derived from human embryonic stem cells.
Chang EA; Beyhan Z; Yoo MS; Siripattarapravat K; Ko T; Lookingland KJ; Madhukar BV; Cibelli JB
Int J Dev Biol; 2010; 54(4):707-15. PubMed ID: 19598107
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
18. Neuronal cell adhesion genes and antidepressant response in three independent samples.
Fabbri C; Crisafulli C; Gurwitz D; Stingl J; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Girolamo GD; Serretti A
Pharmacogenomics J; 2015 Dec; 15(6):538-48. PubMed ID: 25850031
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
20. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
